Completed
ZRDTEfficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in Zanzibar
What is being tested
Data Collection
Who is being recruted
Vector Borne Diseases+3
+ Mosquito-Borne Diseases
+ Infections
+2 Eligibility Criteria
How is the trial designed
Diagnostic Study
Phase 4
Interventional
Study Start: February 2005
Summary
Principal SponsorKarolinska University Hospital
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: February 1, 2005
Actual date on which the first participant was enrolled.The purpose of this study is to assess performance and cost-effectiveness of rapid diagnostic test(RDT) aided malaria diagnosis versus symptom-based/clinical diagnosis in patients of all ages with reported fever last 48 hours alone in primary health care settings in Zanzibar.
Official TitleEfficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in Zanzibar
Principal SponsorKarolinska University Hospital
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
9346 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Diagnostic studies focus on improving how we detect or confirm a disease. They test new tools or techniques that could provide faster or more accurate diagnoses.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Vector Borne DiseasesMosquito-Borne DiseasesInfectionsMalariaParasitic DiseasesProtozoan Infections
Criteria
1 inclusion criteria required to participate
Any patient attending the study sites and reporting history of fever within past 48 hours or other symptoms compatible with malaria and giving their informed consent, will be eligible for the study.
1 exclusion criteria prevent from participating
Patient's refusal to consent will disqualify participation in the study.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
Muyuni, Uzini, Kinyasini and Mzambarauni Primary Health Care Units
Zanzibar, TanzaniaOpen Muyuni, Uzini, Kinyasini and Mzambarauni Primary Health Care Units in Google MapsCompletedOne Study Center